Showing results (311-320 of 686) with videos related to

Sort By:
Pageof 69
Postgraduate Medicine|January 24, 2020
Real-world management of hyperkalemia with patiromer among United States VeteransCsaba P Kovesdy, Elvira O Gosmanova, Steven D Woods, et al.
Journal of Hypertension|August 20, 2010
Blood pressure and survival in long-term hemodialysis patients with and without polycystic kidney diseaseMiklos Z Molnar, Lilia R Lukowsky, Elani Streja, et al.
The Journal of Clinical Endocrinology and Metabolism|April 6, 2016
Hidden Hypercalcemia and Mortality Risk in Incident Hemodialysis PatientsYoshitsugu Obi, Rajnish Mehrotra, Matthew B Rivara, et al.
Circulation. Heart Failure|August 3, 2017
Heart Failure Increases the Risk of Adverse Renal Outcomes in Patients With Normal Kidney FunctionLekha K George, Santhosh K G Koshy, Miklos Z Molnar, et al.
Kidney International Reports|February 19, 2019
Real-World Evaluation of Patiromer for the Treatment of Hyperkalemia in Hemodialysis PatientsCsaba P Kovesdy, Christopher G Rowan, Ansgar Conrad, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 27, 2009
Association of hemodialysis treatment time and dose with mortality and the role of race and sexJessica E Miller, Csaba P Kovesdy, Allen R Nissenson, et al.
American Journal of Nephrology|November 14, 2017
Lymphocyte Cell Ratios and Mortality among Incident Hemodialysis PatientsChristina Catabay, Yoshitsugu Obi, Elani Streja, et al.
Journal of the American College of Cardiology|September 24, 2016
Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal DiseaseElvira O Gosmanova, Margit K Mikkelsen, Miklos Z Molnar, et al.
American Journal of Nephrology|June 8, 2018
Dialysate Potassium and Mortality in a Prospective Hemodialysis CohortAntoney Ferrey, Amy S You, Csaba P Kovesdy, et al.
Pageof 69